AstraZeneca has suspended global clinical trials of its COVID-19
vaccine candidate, created in partnership with the University of Oxford, after
learning of an unexplained illness in one participant. The trials were
temporarily halted to permit an independent panel to evaluate safety data,
according to the drugmaker, which said it is expediting the review.
No comments:
Post a Comment